“Faulty Towers: Understanding the impact of overseas corruption on the London property market” assessed 14 new landmark London developments, worth at least £1.6 billion. It found 4 in 10 of the homes in these developments have been sold to investors from high corruption risk countries or those hiding behind anonymous companies. Less than a quarter had been bought by buyers based in the UK.
In this submission, Transparency International UK’s Pharmaceuticals & Healthcare Programme provides a response to NHS England’s Managing Conflicts of Interest in the NHS: A Consultation.
The UK spends 9.9% of GDP on public and private healthcare, with private expenditure only accounting for 1.5%.1 The NHS England annual budget alone is set to rise to £120 billion with the vast majority being spent on equipment and services.2 The complex nature of the health system, a lack of adequate oversight and this level of resources makes the health sector highly vulnerable to conflicts of interest. Improving the transparency of interactions between NHS staff and other individuals and organisations, and minimising the variation in conflicts of interest rules across the NHS, is vital to fighting corruption.
Our new publication focusing on corrupt wealth in London property. Using multiple data sources, this report finds that there is no data available on the real owners of more than half of the 44,022 land titles owned by overseas companies in London whilst nine out of ten of these properties were bought via secrecy jurisdictions
Spring Cleaning” a new report from Transparency International UK (TI-UK) analyses the role of the UK in providing a safe haven for corrupt wealth from Middle Eastern rulers. In Syria Egypt and Libya, amongst others, corruption played a major role in igniting the “Arab Spring”, with mass protests decrying the misuse of power by political establishments.